What Constitutes a Material ESG Strategy and Its Impact

 

Cameron Balch, Director, of Impact Cooperative gives his analysis of what constitutes a material ESG and the impact it will have on the environment and broader society.

Cameron’s Thoughts:

The last big announcement was the alignment between what the ISSB and what the EU and other jurisdictions have been working on. There have been disagreements in the past on what constitutes a material ESG impact, so how do we determine what impacts your organization?

So from a classical, financial accounting perspective, it’s what impacts the value of your organization, your ability to create value, and that’s just called price value materiality. A new way to think about that on the ESG track is called double materiality. So we look at the fiscal value of the project while also considering its impact on the environment and society as a whole.

So by keeping both of those, it doubles what you’re considering as having an impact on your organization. The EU has been a long-time champion of this. Their original emphasis was on classical materiality, but they are now aligning themselves with the EU to maintain some compatibility between what they are going to publish next year and what is already on the books legally in the European Union.

Follow us on social media for the latest updates in B2B!

Image

Latest

patient
Rebecca Interview: When Peer-to-Peer Reviews Stop Being About the Patient
December 2, 2025

Behind the sterile labels of “inpatient” versus “observation” care is a messy reality: clinicians and insurers often enter peer-to-peer reviews without a shared rulebook, turning what should be a clinical dialogue into a box-checking exercise. The speaker’s frustration points to a broader problem in U.S. healthcare utilization management—decisions about coverage can feel pre-decided,…

Read More
physician advisor
Navigating Payer Denials: A Physician Advisor’s Perspective #2
December 2, 2025

A physician advisor recently described a case that should unsettle anyone who cares about fair, clinically grounded coverage decisions: a Medicaid patient arrived comatose from an overdose, was emergently intubated, developed aspiration pneumonia, and stayed through three midnights before leaving against medical advice. By any bedside standard, this is acute, unstable care—exactly what…

Read More
Inside ERISA Denials: Why Employers May Be the Real Decision-Makers Behind Your Insurance Card
December 2, 2025

Insurance denials aren’t new, but they’re hitting a breaking point right now. As prior authorizations surge and patients face longer delays for everything from imaging to specialty drugs, more providers are realizing that the “payer” on the card often isn’t the one truly holding the reins. A growing share of Americans are covered…

Read More
Laying Out the Landscape in Today’s Patient Monitoring
Laying Out the Landscape in Today’s Patient Monitoring
December 2, 2025

More and more hospital environments rely on continuous, high-quality data to support faster clinical decisions, but much of today’s patient monitoring still varies widely by unit, device, and workflow. This episode kicks off a five-part Health and Life Sciences at the Edge series exploring The Future of Patient Monitoring. Intel’s Kaeli Tully, Solutions Engineer…

Read More